Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Leiomyoma 10Breast Neoplasms 2Fibroma 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1

Interventions

Imatinib Mesylate 2telapristone acetate 1Specimen Handling 1Sirolimus 1Nivolumab 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Hydroxyurea 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Fibroma × telapristone acetate × Clear all
NCT02323646 2019-06-25

Safety and Efficacy of Telapristone Acetate (Proellex®) Administered Vaginally for the Treatment of Uterine Fibroids

Repros Therapeutics Inc.

Phase 2 Completed
42 enrolled 22 charts

Fibroma, Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡